Acerta Pharma B.V. et al v. Pharmacyclics LLC et al > Summary
Court Case Number 1:18-cv-00581
Filing Date Apr 18, 2018
Termination Date Oct 23, 2019
Court Delaware District Court
Status Dismissed - Settled
JudgesRichard G. Andrews
Plaintiff Attorneys
15Acerta Pharma
Attorney Name: Jody Barillare
Acerta Pharma
Attorney Name: Olga Berson
Acerta Pharma
Attorney Name: Amy M. Dudash
Acerta Pharma
Attorney Name: John V. Gorman
Acerta Pharma
Attorney Name: Eric Kraeutler
Acerta Pharma
Attorney Name: Pilar G. Kraman
Acerta Pharma
Attorney Name: David W. Marston Jr.
Acerta Pharma
Attorney Name: Adam W. Poff
Acerta Pharma
Attorney Name: Robert J. Smyth
AstraZeneca
Attorney Name: James Kirkpatrick
AstraZeneca
Attorney Name: Pilar G. Kraman
AstraZeneca
Attorney Name: Adam W. Poff
AstraZeneca
Attorney Name: James Kirkpatrick
AstraZeneca
Attorney Name: Pilar G. Kraman
AstraZeneca
Attorney Name: Adam W. Poff
Defendant Attorneys
5Pharmacyclics
Attorney Name: Michael A. Morin
Pharmacyclics
Attorney Name: Irena Royzman
Pharmacyclics
Attorney Name: Jeremy A. Tigan
AbbVie Inc.
Attorney Name: Michael A. Morin
AbbVie Inc.
Attorney Name: Jeremy A. Tigan
Counter Defendant
12Acerta Pharma
Attorney Name: Jody Barillare
Acerta Pharma
Attorney Name: Amy M. Dudash
Acerta Pharma
Attorney Name: John V. Gorman
Acerta Pharma
Attorney Name: Pilar G. Kraman
Acerta Pharma
Attorney Name: David W. Marston Jr.
Acerta Pharma
Attorney Name: Adam W. Poff
AstraZeneca
Attorney Name: Pilar G. Kraman
AstraZeneca
Attorney Name: Adam W. Poff
AstraZeneca
Attorney Name: Pilar G. Kraman
AstraZeneca
Attorney Name: Adam W. Poff
Acerta Pharma
Attorney Name: Olga Berson
Acerta Pharma
Attorney Name: Eric Kraeutler
Counter Claimant
4Pharmacyclics
Attorney Name: Jeremy A. Tigan
AbbVie Inc.
Attorney Name: Jeremy A. Tigan
Janssen Biotech, Inc.
Attorney Name: Jack B. Blumenfeld
Janssen Biotech, Inc.
Attorney Name: Jeremy A. Tigan
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
07459554 | Imidazopyrazine tyrosine kinase inhibitors | Dec 2, 2008 |